Sg Americas Securities, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 6,730 shares of CPRX stock, worth $163,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,730
Previous 32,812 79.49%
Holding current value
$163,539
Previous $685,000 76.2%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
SELL
$19.53 - $25.74 $509,381 - $671,350
-26,082 Reduced 79.49%
6,730 $163,000
Q4 2024

Jan 17, 2025
BUY
$19.73 - $23.93 $475,532 - $576,760
24,102 Added 276.72%
32,812 $685,000
Q3 2024

Oct 03, 2024
BUY
$15.19 - $21.35 $132,304 - $185,958
8,710 New
8,710 $173,000
Q3 2023

Oct 13, 2023
BUY
$11.69 - $15.02 $502,015 - $645,018
42,944 New
42,944 $502,000
Q1 2023

Apr 28, 2023
BUY
$14.34 - $21.05 $200,788 - $294,742
14,002 Added 87.45%
30,014 $498,000
Q4 2022

Feb 02, 2023
SELL
$12.25 - $19.5 $105,252 - $167,544
-8,592 Reduced 34.92%
16,012 $298,000
Q3 2022

Oct 31, 2022
SELL
$7.06 - $15.52 $464,915 - $1.02 Million
-65,852 Reduced 72.8%
24,604 $316,000
Q2 2022

Jul 29, 2022
SELL
$6.23 - $8.57 $73,383 - $100,946
-11,779 Reduced 11.52%
90,456 $634,000
Q1 2022

Apr 29, 2022
SELL
$5.31 - $8.31 $579,889 - $907,510
-109,207 Reduced 51.65%
102,235 $848,000
Q4 2021

Feb 07, 2022
BUY
$5.21 - $7.45 $631,290 - $902,709
121,169 Added 134.23%
211,442 $1.43 Million
Q3 2021

Nov 01, 2021
BUY
$4.85 - $6.04 $437,824 - $545,248
90,273 New
90,273 $478,000
Q1 2021

May 13, 2021
SELL
$3.45 - $4.69 $35,200 - $47,852
-10,203 Closed
0 $0
Q4 2020

Feb 04, 2021
SELL
$2.97 - $3.83 $299,788 - $386,596
-100,939 Reduced 90.82%
10,203 $34,000
Q3 2020

Nov 09, 2020
BUY
$2.97 - $5.08 $330,091 - $564,601
111,142 New
111,142 $330,000
Q2 2020

Jul 20, 2020
SELL
$3.48 - $5.05 $70,115 - $101,747
-20,148 Closed
0 $0
Q1 2020

Apr 30, 2020
SELL
$2.61 - $5.21 $52,429 - $104,658
-20,088 Reduced 49.93%
20,148 $78,000
Q4 2019

Jan 28, 2020
BUY
$3.67 - $5.7 $147,666 - $229,345
40,236 New
40,236 $151,000
Q3 2018

Nov 06, 2018
SELL
$2.81 - $3.78 $35,338 - $47,537
-12,576 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$2.26 - $3.84 $10,868 - $18,466
-4,809 Reduced 27.66%
12,576 $39,000
Q1 2018

May 03, 2018
BUY
$2.39 - $4.01 $41,550 - $69,713
17,385 New
17,385 $42,000
Q4 2017

Jan 24, 2018
SELL
$2.51 - $4.4 $143,195 - $251,020
-57,050 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$2.4 - $2.94 $136,920 - $167,727
57,050
57,050 $144,000

Others Institutions Holding CPRX

# of Institutions
361
Shares Held
95.5M
Call Options Held
13.4K
Put Options Held
11.7K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.5B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email